Summary
Diabetes mellitus is one of the most common chronic medical conditions. It affects all age groups, has a variety of presentations, a range of complications, and numerous therapeutic interventions. Its impact on patients’ quality of life is dependent on factors such as demographics, the level of glycemic control, and the presence of co-morbidities and diabetic complications. Some of these complications, such as painful diabetic peripheral neuropathy and nocturia, can cause sleep onset and sleep maintenance problems resulting in poor sleep quality, daytime fatigue, and somnolence. Co-morbidities, such as depression, are common in diabetes and may affect sleep and quality of life. Sleep complaints and sleep disorders, such as restless legs syndrome and sleep-related breathing disorders, are very common among adult diabetics. Their impact on the health-related quality of life (HRQoL) of the diabetics, however, has not been extensively studied. Even though there is a multitude of validated quality of life measures that have been used in the diabetic population, few generic and disease-specific questionnaires include sleep-related items. The results of the studies using instruments that incorporate sleep-related questions indicate that sleep complaints contribute significantly to the overall impairment of quality of life in this population. This chapter will review the literature on the relationship between diabetes, some of its complications, HRQoL and sleep quality. It will focus on the most common sleep disorders and describe their impact on quality of life. Finally, it will provide suggestions for further research in this area.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Maddigan SL, Feeny DH, Majumdar SR, Farris KB and Johnson JA. Understanding the determinants of health for people with type 2 diabetes. Am J Public Health 2006; 96(9):1649–55.
McKinlay J, Marceau L. US public health and the 21st century: diabetes mellitus. Lancet 2000; 356(9231):757–61.
Young T, Peppard PE and Gottlieb DJ. Epidemiology of obstructive sleep apnea: A population health perspective. Am J Respir Crit Care Med 2002; 165(9):1217–39.
Phillips B, Hening W, Britz P and Mannino D. Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest 2006; 129(1):76–80.
Garcia-Borreguero D. Time to REST: Epidemiology and burden. Eur J Neurol 2006; 13 Suppl 2:15–20.
Summers MO, Crisostomo MI and Stepanski EJ. Recent developments in the classification, evaluation, and treatment of insomnia. Chest 2006; 130(1):276–86.
Silber MH. Clinical practice. Chronic insomnia. N Engl J Med 2005; 353(8):803–10.
Giles TL, Lasserson TJ, Smith BH, White J, Wright J and Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006;3:CD001106.
Abetz L, Allen R, Follet A, et al. Evaluating the quality of life of patients with restless legs syndrome. Clin Ther 2004; 26(6):925–35.
Giorgi L, Ritchie SY and Kirsch JM. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points–data from the ropinirole clinical trial programme. Curr Med Res Opin 2006;22(10):1867–77.
Oertel WH, Benes H, Bodenschatz R, et al. Efficacy of cabergoline in restless legs syndrome: A placebo-controlled study with polysomnography (CATOR). Neurology 2006; 67(6):1040–6.
Winkelman JW, Sethi KD, Kushida CA, et al. Efficacy and safety of pramipexole in restless legs syndrome. Neurology 2006; 67(6):1034–9.
Trenkwalder C. The weight of evidence for ropinirole in restless legs syndrome. Eur J Neurol 2006; 13 Suppl 3:21–30.
Mallon L, Broman JE and Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration: A 12-year follow-up study of a middle-aged population. Diabetes Care 2005; 28(11):2762–7.
Ayas NT, White DP, Al-Delaimy WK, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 2003; 26(2):380–4.
Yaggi HK, Araujo AB and McKinlay JB. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 2006; 29(3):657–61.
Nilsson PM, Roost M, Engstrom G, Hedblad B and Berglund G. Incidence of diabetes in middle-aged men is related to sleep disturbances. Diabetes Care 2004; 27(10):2464–9.
Gottlieb DJ, Punjabi NM, Newman AB, et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 2005; 165(8):863–7.
Spiegel K, Knutson K, Leproult R, Tasali E and Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol 2005; 99(5):2008–19.
Schultes B, Schmid S, Peters A, Born J and Fehm HL. Sleep loss and the development of diabetes: A review of current evidence. Exp Clin Endocrinol Diabetes 2005; 113(10):563–7.
Sridhar GR, Madhu K. Prevalence of sleep disturbances in diabetes mellitus. Diabetes Res Clin Pract 1994; 23(3):183–6.
Skomro RP, Ludwig S, Salamon E and Kryger MH. Sleep complaints and restless legs syndrome in adult type 2 diabetics. Sleep Med 2001; 2(5):417–22.
Lopes LA, Lins Cde M, Adeodato VG, et al. Restless legs syndrome and quality of sleep in type 2 diabetes. Diabetes Care 2005; 28(11):2633–6.
Unruh ML, Levey AS, D’Ambrosio C, et al. Restless legs symptoms among incident dialysis patients: Association with lower quality of life and shorter survival. Am J Kidney Dis 2004; 43(5):900–9.
Han SY, Yoon JW, Jo SK, et al. Insomnia in diabetic hemodialysis patients. Prevalence and risk factors by a multicenter study. Nephron 2002; 92(1):127–32.
Keinanen-Kiukaanniemi S, Ohinmaa A, Pajunpaa H and Koivukangas P. Health related quality of life in diabetic patients measured by the Nottingham Health Profile. Diabet Med 1996; 13(4):382–8.
Lamond N, Tiggemann M and Dawson D. Factors predicting sleep disruption in Type II diabetes. Sleep 2000; 23(3):415–6.
Knutson KL, Ryden AM, Mander BA and Van Cauter E. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med 2006; 166(16):1768–74.
Kushida CA, Littner MR, Morgenthaler T, et al. Practice parameters for the indications for polysomnography and related procedures: An update for 2005. Sleep 2005; 28(4):499–521.
Resnick HE, Redline S, Shahar E, et al. Diabetes and sleep disturbances: Findings from the Sleep Heart Health Study. Diabetes Care 2003; 26(3):702–9.
Matyka KA, Crawford C, Wiggs L, Dunger DB and Stores G. Alterations in sleep physiology in young children with insulin-dependent diabetes mellitus: Relationship to nocturnal hypoglycemia. J Pediatr 2000; 137(2):233–8.
Jones TW, Porter P, Sherwin RS, et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 1998; 338(23):1657–62.
Pillar G, Schuscheim G, Weiss R, et al. Interactions between hypoglycemia and sleep architecture in children with type 1 diabetes mellitus. J Pediatr 2003; 142(2):163–8.
Pender JR, Pories WJ. Epidemiology of obesity in the United States. Gastroenterol Clin North Am 2005; 34(1):1–7.
Sturm R. Increases in clinically severe obesity in the United States, 1986–2000. Arch Intern Med 2003; 163(18):2146–8.
Punjabi NM, Shahar E, Redline S, et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: The Sleep Heart Health Study. Am J Epidemiol 2004; 160(6):521–30.
Reichmuth KJ, Austin D, Skatrud JB and Young T. Association of sleep apnea and type II diabetes: A population-based study. Am J Respir Crit Care Med 2005; 172(12):1590–5.
Finn L, Young T, Palta M and Fryback DG. Sleep-disordered breathing and self-reported general health status in the Wisconsin Sleep Cohort Study. Sleep 1998; 21(7):701–6.
Baldwin CM, Griffith KA, Nieto FJ, O’Connor GT, Walsleben JA and Redline S. The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. Sleep 2001; 24(1):96–105.
Bergner M, Bobbitt RA, Carter WB and Gilson BS. The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 1981; 19(8):787–805.
Hunt SM, McKenna SP, McEwen J, Williams J and Papp E. The Nottingham Health Profile: Subjective health status and medical consultations. Soc Sci Med [A] 1981; 15(3 Pt 1):221–9.
Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30(6):473–83.
Brorsson B, Ifver J and Hays RD. The Swedish Health-Related Quality of Life Survey (SWED-QUAL). Qual Life Res 1993; 2(1):33–45.
Norris SL. Health-related quality of life among adults with diabetes. Curr Diab Rep 2005; 5(2):124–30.
Wandell PE. Quality of life of patients with diabetes mellitus. An overview of research in primary health care in the Nordic countries. Scand J Prim Health Care 2005; 23(2):68–74.
Wandell P, Brorsson B and Aberg H. Functioning and well-being of patients with type 2 diabetes or angina pectoris, compared with the general population. Diabetes Metab 2000; 26(6):465–71.
Watkins K, Connell CM. Measurement of health-related QOL in diabetes mellitus. Pharmacoeconomics 2004; 22(17):1109–26.
Boyer JG, Earp JA. The development of an instrument for assessing the quality of life of people with diabetes. Diabetes-39. Med Care 1997; 35(5):440–53.
Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). The DCCT Research Group. Diabetes Care 1988; 11(9):725–32.
Hammond GS, Aoki TT. Measurement of health status in diabetic patients. Diabetes impact measurement scales. Diabetes Care 1992; 15(4):469–77.
Wandell PE, Brorsson B and Aberg H. Quality of life in relation to co-morbidity among diabetic patients followed for three years in Swedish primary health care. Diabetes Metab 1999; 25(5):424–8.
Ghanbari A, Yekta ZP, Roushan ZA and Lakeh NM. Assessment of factors affecting quality of life in diabetic patients in Iran. Public Health Nurs 2005; 22(4):311–22.
Wandell PE, Tovi J. The quality of life of elderly diabetic patients. J Diabetes Complications 2000; 14(1):25–30.
Manocchia M, Keller S and Ware JE. Sleep problems, health-related quality of life, work functioning and health care utilization among the chronically ill. Qual Life Res 2001; 10(4):331–45.
Trief PM, Wade MJ, Pine D and Weinstock RS. A comparison of health-related quality of life of elderly and younger insulin-treated adults with diabetes. Age Ageing 2003; 32(6):613–8.
Rose M, Fliege H, Hildebrandt M, Schirop T and Klapp BF. The network of psychological variables in patients with diabetes and their importance for quality of life and metabolic control. Diabetes Care 2002; 25(1):35–42.
Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial. Diabetes Care 1996; 19(3):195–203.
Cox D, Gonder-Frederick L, McCall A, Kovatchev B and Clarke W. The effects of glucose fluctuation on cognitive function and QOL: the functional costs of hypoglycaemia and hyperglycaemia among adults with type 1 or type 2 diabetes. Int J Clin Pract Suppl 2002 ;(129):20–6.
Tabaei BP, Shill-Novak J, Brandle M, Burke R, Kaplan RM and Herman WH. Glycemia and the quality of well-being in patients with diabetes. Qual Life Res 2004; 13(6):1153–61.
Testa MA, Simonson DC and Turner RR. Valuing quality of life and improvements in glycemic control in people with type 2 diabetes. Diabetes Care 1998; 21 Suppl 3:C44–52.
Argoff CE, Backonja MM, Belgrade MJ, et al. Diabetic peripheral neuropathic pain: Consensus guidelines for treatment. J Fam Pract 2006; 55(6):1–20.
Argoff CE, Cole BE, Fishbain DA and Irving GA. Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc 2006; 81(4 Suppl):S3–11.
Galer BS, Gianas A and Jensen MP. Painful diabetic poly-neuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000; 47(2):123–8.
Benbow SJ, Wallymahmed ME and MacFarlane IA. Diabetic peripheral neuropathy and quality of life. QJM 1998; 91(11):733–7.
Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA 1998; 280(21):1831–6.
Backonja MM. Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: A multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus. Epilepsia 1999; 40 Suppl 6:S57, 9; discussion S73–4.
Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998; 50(6):1842–6.
Asplund R. Nocturia, nocturnal polyuria, and sleep quality in the elderly. J Psychosom Res 2004; 56(5):517–25.
Asplund R. Nocturia in relation to sleep, health, and medical treatment in the elderly. BJU Int 2005; 96 Suppl 1:15–21.
Abrams P, Mattiasson A, Lose GR and Robertson GL. The role of desmopressin in the treatment of adult nocturia. BJU Int 2002; 90 Suppl 3:32–6.
Fitzgerald MP, Mulligan M and Parthasarathy S. Nocturic frequency is related to severity of obstructive sleep apnea, improves with continuous positive airways treatment. Am J Obstet Gynecol 2006; 194(5):1399–403.
Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: A randomized, controlled, double-blind trial. JAMA 1998; 280(17):1490–6.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, Totowa, NJ
About this chapter
Cite this chapter
Skomro, R.P. (2008). Sleep and Quality of Life in Diabetes. In: Verster, J.C., Pandi-Perumal, S.R., Streiner, D.L. (eds) Sleep and Quality of Life in Clinical Medicine. Humana Press. https://doi.org/10.1007/978-1-60327-343-5_48
Download citation
DOI: https://doi.org/10.1007/978-1-60327-343-5_48
Publisher Name: Humana Press
Print ISBN: 978-1-60327-340-4
Online ISBN: 978-1-60327-343-5
eBook Packages: MedicineMedicine (R0)